Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha

Cancer Lett. 1998 Jun 5;128(1):65-70. doi: 10.1016/s0304-3835(98)00052-4.

Abstract

To determine whether alteration of PKC alpha expression would affect the metastatic potential of human melanoma cells, replicate cultures of C8161 cells were treated in vitro with a phosphorothioate antisense oligodeoxynucleotide (ODN) that specifically inhibits PKC alpha expression (ISIS-3521). Control C8161 cultures were treated with a scrambled sequence ODN, cationic liposomes or were left untreated. Northern blots demonstrated 70% inhibition of PKC alpha mRNA in ISIS-3521-treated cells compared to controls. Metastasis was suppressed by 75% when ISIS-3521-treated cells were injected intravenously into athymic mice. These results show that PKC alpha expression is important in the regulation of human melanoma metastasis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Humans
  • Isoenzymes / genetics
  • Isoenzymes / metabolism*
  • Lung Neoplasms / secondary
  • Melanoma / enzymology*
  • Mice
  • Mice, Nude
  • Neoplasm Metastasis
  • Oligonucleotides, Antisense / pharmacology*
  • Protein Kinase C / genetics
  • Protein Kinase C / metabolism*
  • Protein Kinase C-alpha
  • RNA / analysis
  • Thionucleotides
  • Tumor Cells, Cultured

Substances

  • Isoenzymes
  • Oligonucleotides, Antisense
  • Thionucleotides
  • RNA
  • PRKCA protein, human
  • Prkca protein, mouse
  • Protein Kinase C
  • Protein Kinase C-alpha